Pertactin antigens extracted from Bordetella pertussis and Bordetella bronchiseptica differ in the isoelectric point

被引:0
|
作者
Cristina Pagliaccia
Roberto Manetti
R. Rappuoli
机构
[1] IRIS,
[2] The Chiron Vaccines Immunobiological Research Institute,undefined
[3] Via Fiorentina 1,undefined
[4] 53100 Siena,undefined
[5] Italy Tel. +39-577-243414; Fax +39-577-243564 email: rappuoli@iris02.biocine.it,undefined
来源
Archives of Microbiology | 1997年 / 168卷
关键词
Key words Pertactin; 69K antigen; Bordetella; pertussis; Bordetella bronchiseptica; Pertussis vaccine; Acellular pertussis vaccine;
D O I
暂无
中图分类号
学科分类号
摘要
Pertactin, which is a membrane-associated antigen of Bordetella pertussis and which is present in many acellular vaccines against whooping cough, has been reported to be similar to the homologous protein in Bordetella bronchiseptica. By running parallel experiments using proteins derived from the two species, we show that the isoelectric point of pertactin from B. pertussis is lower than reported and clearly distinguishable from the homologous protein of B. bronchiseptica.
引用
收藏
页码:437 / 440
页数:3
相关论文
共 50 条
  • [31] Virulence of Pertactin-Negative Bordetella pertussis Isolates from Infants, France
    Bodilis, Helene
    Guiso, Nicole
    EMERGING INFECTIOUS DISEASES, 2013, 19 (03) : 471 - 474
  • [32] IMMUNOCHEMICAL STUDIES ON ANTIGENS OF BORDETELLA PERTUSSIS
    GRIFFITHS, BW
    MASON, MA
    CANADIAN JOURNAL OF MICROBIOLOGY, 1964, 10 (02) : 123 - +
  • [33] ANTIGENS IN SOLUBILIZED BORDETELLA-PERTUSSIS
    WILSON, S
    CANADIAN JOURNAL OF PUBLIC HEALTH, 1967, 58 (01): : 33 - 33
  • [34] Purification design and practice for pertactin, the third component of acellular pertussis vaccine, from Bordetella pertussis
    Li, Zenglan
    Zhang, Yan
    Wang, Qi
    Li, Zhengjun
    Liu, Yongdong
    Zhang, Songping
    Zhang, Guifeng
    Ma, Guanghui
    Luo, Jian
    Su, Zhiguo
    VACCINE, 2016, 34 (34) : 4032 - 4039
  • [35] Bordetella bronchiseptica and Bordetella pertussis: Similarities and Differences in Infection, Immuno-Modulation, and Vaccine Considerations
    Chamorro, Beatriz Miguelena
    De Luca, Karelle
    Swaminathan, Gokul
    Longet, Stephanie
    Mundt, Egbert
    Paul, Stephane
    CLINICAL MICROBIOLOGY REVIEWS, 2023, 36 (03)
  • [36] Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003
    Byrne, S
    Slack, AT
    BMC INFECTIOUS DISEASES, 2006, 6 (1)
  • [37] Prevalence and Genetic Characterization of Pertactin-Deficient Bordetella pertussis in Japan
    Otsuka, Nao
    Han, Hyun-Ja
    Toyoizumi-Ajisaka, Hiromi
    Nakamura, Yukitsugu
    Arakawa, Yoshichika
    Shibayama, Keigo
    Kamachi, Kazunari
    PLOS ONE, 2012, 7 (02):
  • [38] Structure of Bordetella pertussis virulence factor P.69 pertactin
    Emsley, P
    Charles, IG
    Fairweather, NF
    Isaacs, NW
    NATURE, 1996, 381 (6577) : 90 - 92
  • [39] Protective role of immunoglobulin G antibodies to filamentous hemagglutinin and pertactin of Bordetella pertussis in Bordetella parapertussis infection
    He, Q
    Edelman, K
    Arvilommi, H
    Mertsola, J
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (10) : 793 - 798
  • [40] EXPRESSION OF PERTUSSIS TOXIN IN BORDETELLA-BRONCHISEPTICA AND BORDETELLA-PARAPERTUSSIS CARRYING RECOMBINANT PLASMIDS
    LEE, CK
    ROBERTS, A
    PERRIN, S
    INFECTION AND IMMUNITY, 1989, 57 (05) : 1413 - 1418